Development and consideration of global policies for managing the future risks of poliovirus outbreaks: Insights and lessons learned through modeling

Risk Analysis

Volumn 26, Issue 6, 2006, Pages 1571-1580

  Thompson, Kimberly M ^a,b   Duintjer Tebbens, Radboud J ^a   Pallansch, Mark A ^c   Kew, Olen M ^c   Sutter, Roland W ^d   Aylward, R Bruce ^d   Watkins, Margaret ^c   Gary, Howard ^c   Alexander, James P ^c   Venczel, Linda ^c   Johnson, Denise ^c   Cáceres, Victor M ^e   Sangrujee, Nalinee ^f   Jafari, Hamid ^c   Cochi, Stephen L ^c  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c NATIONAL CENTER FOR IMMUNIZATION AND RESPIRATORY DISEASES   (United States)

^d WORLD HEALTH ORGANIZATION   (Switzerland)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f Palladium Group   (United States)

Author keywords

Decision analysis; Dynamic disease model; Outbreak; Polio eradication; Process; Risk analysis; Uncertainty; Variability

Indexed keywords

COST BENEFIT ANALYSIS; DECISION MAKING; DISEASES; HEALTH CARE; RISK ASSESSMENT; VACCINES;

DYNAMIC DISEASE MODEL; GLOBAL POLICIES; POLIO ERADICATION;

PUBLIC POLICY;

INACTIVATED VIRUS VACCINE; ORAL POLIOMYELITIS VACCINE;

HEALTH POLICY; MODELING; PATHOGEN; POLICY DEVELOPMENT; POLIOMYELITIS; QUALITY OF LIFE; RISK FACTOR; VACCINATION; VACCINE; VIRUS;

ARTICLE; COST EFFECTIVENESS ANALYSIS; DEVELOPMENT; ECONOMIC ASPECT; EPIDEMIC; ERADICATION THERAPY; HEALTH CARE POLICY; HEALTH SURVEY; HUMAN; MEDICAL DECISION MAKING; MODEL; POLIOMYELITIS; POLIOMYELITIS VIRUS; QUALITY OF LIFE; RETROSPECTIVE STUDY; RISK MANAGEMENT; VACCINATION;

CENTERS FOR DISEASE CONTROL AND PREVENTION (U.S.); COST-BENEFIT ANALYSIS; DISEASE OUTBREAKS; HEALTH POLICY; HUMANS; IMMUNIZATION PROGRAMS; INTERNATIONAL COOPERATION; MASS IMMUNIZATION; MODELS, THEORETICAL; POLIOMYELITIS; PUBLIC HEALTH; RISK ASSESSMENT; RISK MANAGEMENT; UNITED STATES; WORLD HEALTH;

POLIOVIRUS;

EID: 33845656995     PISSN: 02724332     EISSN: 15396924     Source Type: Journal    
DOI: 10.1111/j.1539-6924.2006.00841.x     Document Type: Article

References (24)

1. Sterman, J. (2002). All models are wrong: Reflections on becoming a systems scientist. System Dynamics Review, 18(4), 525.
2. Box, G. (1979). Robustness in the strategy of scientific model building. In R. Launer & G. Wilkinson (Eds.), Robustness in Statistics (p. 202). New York: Academic Press.
3. Sterman, J. (2000). Business Dynamics: Systems Thinking and Modeling for a Complex World. Boston: McGraw-Hill.
4. Thompson, K. M., & Graham, J. D. (1996). Going beyond the single number: Using probabilistic risk assessment to improve risk management. Human and Ecological Risk Assessment, 2(4), 1008-1034.
5. Thompson, K. M., & Duintjer Tebbens, R. J. (2006). Retrospective cost-effectiveness analyses for polio vaccination in the United States. Risk Analysis, 26(6), 1423-1440.
6. Centers for Disease Control and Prevention. (2006). Imported vaccine-associated paralytic poliomyelitis - United States, 2005. Morbidity and Mortality Weekly Report, 55(4), 97-99.
7. Francis, T. Jr., Korns, R. F., Voight, R. B., Boisen, M., Hemphill, F. M., Napier, J. A. & Tolchinsky, E. (1955). An evaluation of the 1954 poliomyelitis vaccine trials. Summary report. American Journal of Public Health, 45(Part II, May Supplement), 1-51.
8. Sutter, R. W., Kew, O. M., & Cochi, S. L. (2004). Poliovirus vaccine - Live. In S. A. Plotkin & W. A. Orenstein (Eds.), Vaccines. 4th ed., (pp. 651-705), Philadelphia: W.B. Saunders.
9. Centers for Disease Control and Prevention. (1994). Certification of poliomyelitis eradication - The Americas, 1994. Morbidity and Mortality Weekly Report, 43, 720-722.
10. de Quadros, C. A., Andrus, J. K., Olive, J.-M., Guerra de Macedo, C., & Henderson, D. A. (1992). Polio eradication from the western hemisphere. Annual Reviews of Public Health, 13, 239-252.
11. Alexander, L. N., Seward, J. F., Santibanez, T. A., Pallansch, M. A., Kew, O. M., Prevots, D. R., Strebel, P. M., Cono, J., Wharton, M., Orenstein, W. A., Sutter, R. W. (2004). Vaccine policy changes and epidemiology of poliomyelitis in the United States. Journal of the American Medical Association, 292(14), 1696-1701.
12. Miller, M. A., Sutter, R. W., Strebel, P. M., & Hadler, S. C. (1996). Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule. Journal of the American Medical Association, 276(12), 967-971.
13. World Health Assembly. (1988). Global Eradication of Poliomyelitis by the Year 2000 (Resolution 41.28). Geneva: World Health Organization.
14. Centers for Disease Control and Prevention. (2006). Resurgence of wild poliovirus type 1 transmission and consequences of importation - 21 previously polio-free countries, 2002-2005. Morbidity and Mortality Weekly Report, 55(6), 145-150.
15. Sangrujee, N., Duintjer Tebbens, R. J., Cáceres, V. M., & Thompson, K. M. (2003). Policy decision options during the first 5 years following certification of polio eradication. Medscape General Medicine, 5(4), 35.
16. Kew, O. M., Sutter, R. W., de Gourville, E., Dowdle, W. R., & Pallansch, M. A. (2005). Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Annual Review of Microbiology, 59, 587-635.
17. DuintjerTebbens, R. J., Pallansch, M. A., Kew, O. M., Cáceres, V. M., Jafari, H., Cochi, S. L., Aylward, R. B., & Thompson, K. M. (2006). Risks of paralytic disease due to wild or vaccine-derived poliovirus after eradication. Risk Analysis, 26(6), 1471-1505.
18. Anderson, R. M., & May, R. M. (1991). Infectious Diseases of Humans: Dynamics and Control. New York: Oxford University Press.
19. Aylward, R. B., Acharya, A., England, S., Agocs, M., & Linkins, J. (2003). Global health goals: Lessons from the worldwide effort to eradicate poliomyelitis. Lancet, 362(9387), 909-14.
20. Merkhofer, M. W., & Keeney, R. L. (1987). A multiattribute utility analysis of alternative sites for the disposal of nuclear waste. Risk Analysis, 7(2), 173-194.
21. DuintjerTebbens, R. J., Pallansch, M. A., Kew, O. M., Cáceres, V. M., Sutter, R. W., & Thompson, K. M. (2005). A dynamic model of poliomyelitis outbreaks: Learning from the past to help inform the future. American Journal of Epidemiology, 162(4), 358-372.
22. Duintjer Tebbens, R. J., Sangrujee, N., Thompson, K. M. (2006). The costs of polio risk management policies after eradication. Risk Analysis, 26(6), 1507-1531.
23. Thompson, K. M., Duintjer Tebbens, R. J., & Pallansch, M. A. (2006). Evaluation of response scenarios to potential polio outbreaks using mathematical models. Risk Analysis, 26(6), 1541-1556.
24. Duintjer Tebbens, R. J., Thompson, K. M., Huninck, M., Mazzuchi, T. M., Lewandowski, D., Kurowicka, D., & Cooke, R. M. (2006). Sensitivity analyses of a dynamic economic evaluation model for vaccination programs. Risk Analysis, 26(6).